Trader consensus on a 93.5% probability of no new pandemic in 2026 reflects the absence of any novel pathogen achieving sustained global human-to-human transmission through mid-August, despite the WHO-declared PHEIC for the Bundibugyo Ebola outbreak in the DRC and Uganda. Regional surges in chikungunya, dengue, mpox clade I, and hantavirus remain geographically limited, with no evidence of exponential growth or reassortment enabling pandemic potential per CDC and WHO surveillance. Post-COVID improvements in genomic sequencing and early-warning systems have further lowered escalation risk. However, uncertainty persists around viral evolution in reservoir species or undetected zoonotic spillovers that could accelerate international spread before year-end.